Atlas Trials

MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab

Clinical trial NCT04554836 · COMPLETED

Trial details

NCT number
NCT04554836
Sponsor
TheraOp
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the ColonAdenocarcinoma of the Rectum
Start date
2020-12-29
Primary completion
2024-06-11
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.